Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Cancer Immunotherapy Market Expected to Be in 2029?

Over the past few years, there has been a significant increase in the size of the cancer immunotherapy market. It is projected to rise from $110.91 billion in 2024 to $124.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this growth during the historic period include the escalating incidence of cancer, the preferential shift towards immunotherapy over traditional therapy, the surge in research and development activities aimed at creating targeted disease treatments, enhanced efficacy and preciseness of novel therapies, and an increasing awareness of the shortcomings associated with conventional cancer treatments.

The market size of cancer immunotherapy is predicted to undergo swift expansion in the coming years, rising to “$189.5 billion by 2029 with a compound annual growth rate (CAGR) of 11.2%.” This robust growth projected for the forecast period can be attributed to factors such as increased approval of innovative immunotherapies for cancer, heightened demand for personalized treatment, growing detection of cancer in individuals, increased investment in clinical trials for developing state-of-the-art treatments, and heightened awareness about cancer immunotherapy. Some of the main trends anticipated during the forecast period encompass the inception of adoptive cell therapies like car-t cells, investigation into the use of oncolytic viruses in cancer immunotherapy, creation of personalized cancer vaccines, application of artificial intelligence in immunotherapy research, and increased focus on real-world evidence and patient outcomes in treatment decisions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp

What Are The Contributors To Demand In The Cancer Immunotherapy Market?

The cancer immunotherapy market is projected to expand due to the increasing occurrences of cancer. The global surge in cancer cases is attributed to factors such as tobacco use, alcohol consumption, obesity, lack of physical activity, and environmental elements. The rise in cancer diagnoses is projected to elevate the demand for cancer immunotherapies, as patients are progressively seeking medical treatments that offer enhanced recuperation and less discomfort. For example, the European Union Science Hub, the Joint Research Centre of the European Commission based in Belgium, reported in October 2023 that new incidents of cancer had grown by 2.3% over the prior two years, amounting to 2.74 million in 2022. In the same period, cancer deaths also rose by 2.4%. Consequently, this surge in cancer cases is anticipated to stimulate the demand for cancer immunotherapy in the future.

What Segmentation Categories Are Included In The Cancer Immunotherapy Market Analysis?

The cancer immunotherapy market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

What Upcoming Trends Are Expected To Impact The Cancer Immunotherapy Market Globally?

The prominence of advanced technologies in cancer immunotherapy is a significant trend being noticed in the cancer immunotherapy market. An uptick has been noticed in the application of various innovative technologies and numerous therapies that aid the immune system to recognize and counteract tumors using a range of therapies and technologies like immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy. These advanced methods may greatly impact the prognosis and treatment of cancer. For instance, in October 2022, AstraZeneca plc, a biotechnology and pharmaceutical company based in the UK, reported receiving approval for its drug, Capivasertib, paired with Faslodex. This particular drug, a cancer immunotherapy, has been created to treat breast cancer and has been revealed to be effective when used after the cancer has recurred or advanced following endocrine therapy, targeting locally advanced or metastatic breast cancer with low or negative human epidermal growth factor receptor 2 (HER2).

Who Are The Top-Ranked Companies In The Cancer Immunotherapy Market Today?

Major companies operating in the cancer immunotherapy market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, 3D Signatures Inc., Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, Kura Oncology Inc., MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Pulse Biosciences Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report

How Is Cancer Immunotherapy Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6768&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model